In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
Amarnath Yatra is starting again on Monday. The yatra was postponed following a cloudburst after
A common question is being raised in some circles of the American media. And that is, is Presiden
A strange case has emerged in Thailand. Here a man accidentally left his wife midway during a roa
Texas police arrested Richardson, a high school student after he was seen walking to school with
Akshay Kumar: 'One should accept the failure of his films', Rajatav Dutta praised Akshay's statement
Bollywood player Kumar i.e. Akshay Kumar is in discussion about his film 'Selfie'. Akshay's film
News related to Shahrukh Khan's upcoming film 'Jawan' has come out. According to recent reports,
England has won the four-match T20 series 2-0. In the last T20 International match, England defea
The company has increased the price of Xiaomi's Redmi Note 10 Pro, one of the biggest smartphone
Union Home and Cooperation Minister Amit Shah said that after 75 years of independence, the count
Petrol prices have shocked the people. The higher the use of petrol and diesel in the country, th
